查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519525

2024-2032 年按產品、適應症、配銷通路和地區分類的馬保健市場

Equine Healthcare Market by Product, Indication, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球馬保健市場規模達15億美元。馬匹數量的快速增加、馬主對馬匹健康和適當營養的認知不斷提高以及先進成像技術的利用是推動市場發展的一些關鍵因素。

馬醫療保健是獸醫學的一個分支，專注於馬疾病的診斷、治療和預防。它涉及各種產品的利用，如疫苗、驅蟲劑、局部治療、關節補充劑、益生元、滅蠅噴霧劑、蹄部調理劑、防腐劑和功能添加劑。馬醫療保健包括預防護理、疾病管理、跛行治療、生殖護理、口腔衛生、復健和解決行為問題。它有助於改善整體健康，預防未來的併發症，允許早期疾病檢測，促進成功繁殖，促進更長的壽命，並降低嚴重疾病的風險，如跛行、牙齒問題、感染、肥胖、皰疹和狂犬病。

馬保健市場趨勢：

由於馬匹廣泛用於賽馬、農耕和作為伴侶，馬匹數量迅速增加，這是推動市場成長的主要因素之一。馬保健服務和產品，如預防保健、生殖服務、復健中心、疫苗和保健品，被廣泛使用，以確保最佳性能、預防併發症、防止受傷並降低疾病風險。除此之外，馬主對馬健康和適當營養重要性的認知不斷提高，也是另一個促進生長的因素。此外，政府實施的各種支持動物福利、促進負責任的所有權和提供高品質醫療設施的措施正在對市場成長產生積極影響。此外，利用先進的成像技術，如數位射線照相、超音波和內視鏡檢查，提供馬身體的詳細橫斷面影像，從而可以診斷肌肉骨骼損傷、跛行和內科疾病，正在為市場做出貢獻。除此之外，最近開發的馬匹穿戴式健康監測設備可以持續監測生命徵象、活動量和行為，以便及早發現任何健康問題，這為市場成長提供了動力。此外，賽馬、障礙賽、盛裝舞步和耐力賽等馬術運動的不斷增加正在推動市場的成長。其他因素，包括消費者支出能力的提高、寵物人性化的新興趨勢、廣泛的研發（R＆D）活動以及電子商務行業的快速擴張，預計將推動市場成長。

本報告回答的關鍵問題：

  • 迄今為止，全球馬保健市場表現如何，未來幾年將如何表現？
  • 全球馬保健市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球馬保健市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的馬匹保健市場？
  • 基於產品的市場區隔是什麼？
  • 馬保健市場上最具吸引力的產品是什麼？
  • 根據指示，市場的細分是什麼？
  • 馬保健市場上最具吸引力的適應症是什麼？
  • 基於配銷通路的市場區隔是什麼？
  • 馬保健品市場中哪個配銷通路最具吸引力？
  • 全球馬匹保健市場的競爭結構如何？
  • 誰是全球馬保健市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球馬保健市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 藥品
    • 市場走向
    • 關鍵環節
      • 抗發炎藥
      • 殺寄生蟲藥
      • 其他
    • 市場預測
  • 疫苗
    • 市場走向
    • 關鍵環節
      • 減毒活疫苗
      • 重組疫苗
      • 其他
    • 市場預測
  • 藥用飼料添加劑
    • 市場走向
    • 市場預測
  • 診斷
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依跡象

  • 肌肉骨骼疾病
    • 市場走向
    • 市場預測
  • 寄生蟲控制
    • 市場走向
    • 市場預測
  • 馬皰疹病毒
    • 市場走向
    • 市場預測
  • 馬腦脊髓炎
    • 市場走向
    • 市場預測
  • 馬流感
    • 市場走向
    • 市場預測
  • 西尼羅病毒
    • 市場走向
    • 市場預測
  • 破傷風
    • 市場走向
    • 市場預測
  • 狂犬病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 獸醫醫院和診所
    • 市場走向
    • 市場預測
  • 零售藥局和藥局
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Boehringer Ingelheim International GmbH
    • Ceva
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Esaote SpA
    • Hallmarq Veterinary Imaging
    • IDEXX Laboratories Inc.
    • Merck & Co. Inc.
    • Vetoquinol SA
    • Zoetis Inc
Product Code: SR112024A7779

The global equine healthcare market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.

Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.

Equine Healthcare Market Trends:

The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global equine healthcare market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, indication, and distribution channel.

Product Insights:

Drugs

Anti-Inflammatory Drugs

Parasiticide Drugs

Others

Vaccines

Live Attenuated Vaccine

Recombinant Vaccine

Others

Medicated Feed Additives

Diagnostics

Others

The report has provided a detailed breakup and analysis of the equine healthcare market based on the product. This includes drugs (anti-inflammatory drugs, parasiticide drugs, and others), vaccines (live attenuated vaccine, recombinant vaccine, and others), medicated feed additives, diagnostics, and others. According to the report, drugs represented the largest segment.

Indication Insights:

Musculoskeletal Disorders

Parasite Control

Equine Herpes Virus

Equine Encephalomyelitis

Equine Influenza

West Nile Virus

Tetanus

Rabies

Others

A detailed breakup and analysis of the equine healthcare market based on the indication has also been provided in the report. This includes musculoskeletal disorders, parasite control, equine herpes virus, equine encephalomyelitis, equine influenza, West Nile virus, tetanus, rabies, and others. According to the report, parasite control accounted for the largest market share.

Distribution Channel Insights:

Veterinary Hospitals and Clinics

Retail Pharmacies and Drug Stores

A detailed breakup and analysis of the equine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals and clinics and retail pharmacies and drug stores. According to the report, veterinary hospitals and clinics accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global equine healthcare market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global equine healthcare market?
  • What is the impact of each driver, restraint, and opportunity on the global equine healthcare market?
  • What are the key regional markets?
  • Which countries represent the most attractive equine healthcare market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the equine healthcare market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the equine healthcare market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the equine healthcare market?
  • What is the competitive structure of the global equine healthcare market?
  • Who are the key players/companies in the global equine healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Equine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anti-Inflammatory Drugs
      • 6.1.2.2 Parasiticide Drugs
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Live Attenuated Vaccine
      • 6.2.2.2 Recombinant Vaccine
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Medicated Feed Additives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostics
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Musculoskeletal Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parasite Control
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Equine Herpes Virus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Equine Encephalomyelitis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Equine Influenza
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 West Nile Virus
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Tetanus
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Rabies
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Others
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Ceva
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Dechra Pharmaceuticals PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Elanco Animal Health Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Esaote SpA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Hallmarq Veterinary Imaging
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 IDEXX Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Vetoquinol S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zoetis Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Equine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Equine Healthcare Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Equine Healthcare Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Equine Healthcare Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Equine Healthcare Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Equine Healthcare Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Equine Healthcare Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Equine Healthcare (Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Equine Healthcare (Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Equine Healthcare (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Equine Healthcare (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Equine Healthcare (Medicated Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Equine Healthcare (Medicated Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Equine Healthcare (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Equine Healthcare (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Equine Healthcare (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Equine Healthcare (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Equine Healthcare (Musculoskeletal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Equine Healthcare (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Equine Healthcare (Parasite Control) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Equine Healthcare (Parasite Control) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Equine Healthcare (Equine Herpes Virus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Equine Healthcare (Equine Herpes Virus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Equine Healthcare (Equine Encephalomyelitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Equine Healthcare (Equine Encephalomyelitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Equine Healthcare (Equine Influenza) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Equine Healthcare (Equine Influenza) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Equine Healthcare (West Nile Virus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Equine Healthcare (West Nile Virus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Equine Healthcare (Tetanus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Equine Healthcare (Tetanus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Equine Healthcare (Rabies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Equine Healthcare (Rabies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Equine Healthcare (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Equine Healthcare (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Equine Healthcare Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Equine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Equine Healthcare Industry: Value Chain Analysis
  • Figure 91: Global: Equine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Equine Healthcare Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Equine Healthcare Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Equine Healthcare Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Equine Healthcare Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Equine Healthcare Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Equine Healthcare Market: Competitive Structure
  • Table 7: Global: Equine Healthcare Market: Key Players